FibroGen (STU:1FG) E10 : €-2.11 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is FibroGen E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

FibroGen's adjusted earnings per share data for the three months ended in Mar. 2024 was €-0.304. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-2.11 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-20), FibroGen's current stock price is €0.922. FibroGen's E10 for the quarter that ended in Mar. 2024 was €-2.11. FibroGen's Shiller PE Ratio of today is .

FibroGen E10 Historical Data

The historical data trend for FibroGen's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroGen E10 Chart

FibroGen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

E10

Get a 7-Day Free Trial

-1.72

-2.08

FibroGen Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
E10	Get a 7-Day Free Trial															-1.80	-1.84	-2.11	-2.08	-2.11

Competitive Comparison of FibroGen's E10

For the Biotechnology subindustry, FibroGen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FibroGen's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroGen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where FibroGen's Shiller PE Ratio falls into.

FibroGen E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, FibroGen's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS	=	Earnings per Share (Diluted)	/	CPI of Mar. 2024 (Change)	*	Current CPI (Mar. 2024)
	=	-0.304	/	131.7762	*	131.7762
	=	-0.304

Current CPI (Mar. 2024) = 131.7762.

FibroGen Quarterly Data

	per share eps	CPI	Adj_EPS
201406	0.282	100.560	0.370
201409	-0.551	100.428	-0.723
201412	-0.694	99.070	-0.923
201503	-0.721	99.621	-0.954
201506	0.740	100.684	0.969
201509	-0.659	100.392	-0.865
201512	-0.780	99.792	-1.030
201603	-0.404	100.470	-0.530
201606	0.312	101.688	0.404
201609	-0.339	101.861	-0.439
201612	-0.465	101.863	-0.602
201703	-0.449	102.862	-0.575
201706	-0.409	103.349	-0.521
201709	-0.268	104.136	-0.339
201712	-0.228	104.011	-0.289
201803	-0.405	105.290	-0.507
201806	-0.240	106.317	-0.297
201809	-0.429	106.507	-0.531
201812	0.202	105.998	0.251
201903	-0.469	107.251	-0.576
201906	1.115	108.070	1.360
201909	-0.518	108.329	-0.630
201912	-1.008	108.420	-1.225
202003	-0.805	108.902	-0.974
202006	-0.844	108.767	-1.023
202009	0.297	109.815	0.356
202012	-0.526	109.897	-0.631
202103	-0.655	111.754	-0.772
202106	-1.204	114.631	-1.384
202109	0.459	115.734	0.523
202112	-1.283	117.630	-1.437
202203	-0.617	121.301	-0.670
202206	-0.738	125.017	-0.778
202209	-0.990	125.227	-1.042
202212	-0.661	125.222	-0.696
202303	-0.757	127.348	-0.783
202306	-0.831	128.729	-0.851
202309	-0.609	129.860	-0.618
202312	-0.523	129.419	-0.533
202403	-0.304	131.776	-0.304

Add all the adjusted EPS together and divide 10 will get our e10.

FibroGen (STU:1FG) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.

FibroGen E10 Related Terms

Thank you for viewing the detailed overview of FibroGen's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroGen (STU:1FG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroGen Inc (STU:1FG) » Definitions » E10

Comparable Companies

Traded in Other Exchanges

FGEN:USA FGEN:Mexico 0IL8:UK

Address

409 Illinois Street, San Francisco, CA, USA, 94158

Website

https://www.fibrogen.com

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

FibroGen (STU:1FG) Headlines

No Headlines